Frontage Holdings Reports Significant Profit Growth in Q3 2025
I'm PortAI, I can summarize articles.
Frontage Holdings Corp. reported its Q3 2025 financial results, showing a revenue increase to approximately US$191.4 million for the nine months ending September 30, 2025. Net profit surged to US$5.6 million, up from US$0.2 million in 2024, with an adjusted net profit rise of 32.5% to US$12.6 million. The company operates in the pharmaceutical and biotechnology sector, providing drug development services. The current analyst rating for its stock (HK:1521) is a Hold with a price target of HK$1.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments